- Home
- ALVR vs AITR Comparison
ALVR vs AITR Comparison
Compare ALVR & AITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- AITR
- Stock Information
- Founded
- ALVR 2013
- AITR 2022
- Country
- ALVR United States
- AITR United States
- Employees
- ALVR N/A
- AITR N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- AITR
- Sector
- ALVR Health Care
- AITR
- Exchange
- ALVR Nasdaq
- AITR Nasdaq
- Market Cap
- ALVR 87.7M
- AITR 82.6M
- IPO Year
- ALVR 2020
- AITR 2023
- Fundamental
- Price
- ALVR $0.94
- AITR $10.54
- Analyst Decision
- ALVR Sell
- AITR
- Analyst Count
- ALVR 5
- AITR 0
- Target Price
- ALVR $1.00
- AITR N/A
- AVG Volume (30 Days)
- ALVR 155.6K
- AITR 71.3K
- Earning Date
- ALVR 11-04-2024
- AITR 01-01-0001
- Dividend Yield
- ALVR N/A
- AITR N/A
- EPS Growth
- ALVR N/A
- AITR N/A
- EPS
- ALVR N/A
- AITR N/A
- Revenue
- ALVR N/A
- AITR N/A
- Revenue This Year
- ALVR N/A
- AITR N/A
- Revenue Next Year
- ALVR N/A
- AITR N/A
- P/E Ratio
- ALVR N/A
- AITR N/A
- Revenue Growth
- ALVR N/A
- AITR N/A
- 52 Week Low
- ALVR $0.58
- AITR $10.11
- 52 Week High
- ALVR $2.49
- AITR $10.57
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- AITR 78.43
- Support Level
- ALVR $0.74
- AITR $10.51
- Resistance Level
- ALVR $0.91
- AITR $10.57
- Average True Range (ATR)
- ALVR 0.06
- AITR 0.01
- MACD
- ALVR 0.01
- AITR -0.00
- Stochastic Oscillator
- ALVR 94.50
- AITR 83.33
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About AITR AI TRANSPORTATION ACQUISITION CORP Ordinary shares
AI Transportation Acquisition Corp is a blank check company.